A First-in-human Clinical Trial Evaluating a Novel Colonic Intraluminal Endoscopic Support Structure (CIESS)
1 other identifier
interventional
4
0 countries
N/A
Brief Summary
The aim of the first-in-human clinical trial is to evaluate the feasibility of performing colonoscopic polypectomy with a novel colonic intraluminal endoscopic support structure (CIESS) in-situ
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2025
CompletedStudy Start
First participant enrolled
December 18, 2025
CompletedFirst Posted
Study publicly available on registry
December 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 18, 2026
December 31, 2025
December 1, 2025
1 year
December 8, 2025
December 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Ability to deploying CIESS in a single attempt
Primary outcome measure is whether the CIESS can be deployed successfully in a single attempt - this is a measure of the feasibility of deploying the CIESS during colonoscopy. This outcome will be recorded as "successfully deployed in a single attempt or unsuccessfully deployed in a single attempt"
From enrollment to end of treatment at 4 weeks
Study Arms (1)
Colonoscopy and polypectomy with Colonic Intraluminal Endoscopic Support Structure in-situ
EXPERIMENTALInterventions
During colonoscopy, if a left-sided colonic polyps is identified, the colonic intraluminal endoscopic support structure (CIESS) will be deployed. Routine polypectomy will be performed. CIESS will be retrieved after polypectomy is completed. Colonoscopy will be completed as per normal routine.Other Name:
Eligibility Criteria
You may qualify if:
- Positive fecal occult blood test
- ASA I/II
- only patients with left-sided colonic polyp during colonoscopy will be included into the study eventually
You may not qualify if:
- History of malignancy, gastrointestinal tract/ abdominal surgery, diverticular disease, abdominal/ pelvic radiation
- Pregnancy patient
- cognitively impaired patients
- Patients on blood thinners or anticoagulants
- ASA III / ASA IV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- JurongHealthlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2025
First Posted
December 31, 2025
Study Start
December 18, 2025
Primary Completion (Estimated)
December 18, 2026
Study Completion (Estimated)
December 18, 2026
Last Updated
December 31, 2025
Record last verified: 2025-12